Gene silencing studies demonstrate clear antiproliferative effects of JmjD2A knockdown in (estrogen receptor [ER]-negative breast cancer cells [149], and downregulation of JmjD2A in ER-positive breast cancer cells leads to reduced cell proliferation associated with decreased levels of cyclin D1 [150]. The gene discussed is ESR1; the disease is breast cancer.